KRRO — Korro Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Korro Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	217	220	131	83.1	166
Net Total Accounts Receivable
Net Total Receivables	0.805	0.34	0.144	0.449	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	221	225	135	87.5	173
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.76	37.8	36.9	31.7	42.8
Long Term Investments
Other Long Term Assets
Total Assets	223	265	185	121	222
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	52.8	26.6	11.4	21	19.5
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	55.9	72.2	54.5	52	51.8
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	167	192	131	69.2	170
Total Liabilities & Shareholders' Equity	223	265	185	121	222
Total Common Shares Outstanding